NCT06993662View on ClinicalTrials.gov

The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

December 20, 2027

Study Completion Date

December 20, 2027

Conditions
AnxietyDepressionObsessive-compulsive DisorderPersonality DisorderBipolar DisorderSchizophreniaPsychotic DisordersPTSD
Interventions
COMBINATION_PRODUCT

Group A. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by anxiety disorders and depression.

The combination of pharmacotherapy (anxiolytics (tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI) and individual cognitive behavioral psychotherapy by anxiety disorders and depression.

COMBINATION_PRODUCT

Group B. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by PTSD

The combination of pharmacotherapy (anxiolytics (tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI) and individual cognitive behavioral psychotherapy by PTSD

COMBINATION_PRODUCT

Group C. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by obsessive-compulsive disorder.

The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by obsessive-compulsive disorder.

COMBINATION_PRODUCT

Group D.The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by bipolar disorder

The combination of pharmacotherapy (anxiolytics (tavor, clonotril, lexotanil) antidepressants (SSRI, SNRI), mood stabilizers (lithium, depakine), antipsychotics (clozapine and atypical antipsychotics)) and individual cognitive behavioral psychotherapy by bipolar disorder.

COMBINATION_PRODUCT

Group E. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by schizophrenia and psychotic disorders

The combination of pharmacotherapy (anxiolytics(tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI), antipsychotics (clozapine and atypical antipsychotics)) and individual cognitive behavioral psychotherapy by schizophrenia and psychotic disorders.

COMBINATION_PRODUCT

Group F.The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by personality disorders

The combination of pharmacotherapy (anxiolytics (tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI), antipsychotics (clozapine and atypical antipsychotics) and individual cognitive behavioral psychotherapy by personality disorders.

Trial Locations (1)

15771

RECRUITING

Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE, Athens

All Listed Sponsors
lead

Rakitzi, Stavroula

OTHER